Verified peer comparison
AstraZeneca vs Bristol-Myers Squibb Financial Comparison
Direct answer
AstraZeneca and Bristol-Myers Squibb are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free AstraZeneca email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- AstraZeneca Revenue
- 58,739,000,000 USD
- Bristol-Myers Squibb Revenue
- 48,195,000,000 USD
- AstraZeneca Operating income
- 13,743,000,000 USD
- Bristol-Myers Squibb Operating income
- 13,724,000,000 USD